Katarzyna Piwocka

11PUBLICATIONS
60CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 29, 2026
TIAR-dependent coordination of alternative splicing and lipid peroxidation is required for CML cell resistance to imatinib in the bone marrow stroma.

|Dec 02, 2024
High-throughput formulation of reproducible 3D cancer microenvironments for drug testing in myeloid leukemia.

M Rudzinska-Radecka, L Turos-Korgul, D Mukherjee

|Mar 29, 2023
Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy.

Agnieszka Synowiec, Klaudia Brodaczewska, Gabriel Wcisło

|Dec 11, 2022
Pre-Existing and Acquired Resistance to PARP Inhibitor-Induced Synthetic Lethality.

Bac Viet Le, Paulina Podszywałow-Bartnicka, Katarzyna Piwocka

|Feb 07, 2022
4-1BBL-containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells.

Julian Swatler, Laura Turos-Korgul, Marta Brewinska-Olchowik

|Oct 23, 2021
Comparison of Differentiation Pattern and WNT/SHH Signaling in Pluripotent Stem Cells Cultured under Different Conditions.

Barbara Świerczek-Lasek, Damian Dudka, Damian Bauer

Pageof 2

Frequent Collaborators

4 joint publications

Laura Turos-Korgul

3 joint publications

Ewa Kozlowska

3 joint publications

Agata Kominek

3 joint publications

Marta Brewinska-Olchowik